Neumora Therapeutics (NMRA) Interest Coverage Ratio (2022 - 2026)

Neumora Therapeutics' Interest Coverage Ratio history runs 5 years deep, the most recent figure standing at 28.51 for Q1 2026.

• On a quarterly basis, Interest Coverage Ratio changed N/A year-over-year to 28.51 in Q1 2026; TTM through Mar 2026 was 57.35, a N/A change from a year earlier, with the FY2025 full-year figure at 0.73, up 26.71% from the prior year.
• Interest Coverage Ratio climbed to 28.51 in Q1 2026 per NMRA's latest filing, from 28.72 in the prior quarter.
• Across five years, Interest Coverage Ratio topped out at 0.22 in Q4 2022 and bottomed at 57.7 in Q3 2025.
• The 5-year median for Interest Coverage Ratio is 1.26 (2024), against an average of 16.87.
• Across the five-year window, Interest Coverage Ratio slumped 110.35% in 2024 and sank 5392.29% in 2025, its largest moves.
• Year by year, Interest Coverage Ratio stood at 0.22 in 2022, then sank by 257.47% to 0.78 in 2023, then tumbled by 35.43% to 1.05 in 2024, then sank by 2634.05% to 28.72 in 2025, then rose by 0.73% to 28.51 in 2026.
• Per Business Quant, the three latest NMRA Interest Coverage Ratio figures stand at 28.51 (Q1 2026), 28.72 (Q4 2025), and 57.7 (Q3 2025).